PubRank

M Turck

Author PubWeight™ 269.55‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966 159.00
2 Etiology of nongonococcal urethritis. N Engl J Med 1975 9.61
3 Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 1982 8.75
4 Causes of the acute urethral syndrome in women. N Engl J Med 1980 6.91
5 A critical evaluation of nalidixic acid in urinary-tract infections. N Engl J Med 1966 5.80
6 Nalidixic acid and oxolinic acid in the treatment of chronic bacteriuria. Ann Intern Med 1969 4.41
7 Evaluation of cefazolin, a new cephalosporin antibiotic. Antimicrob Agents Chemother 1973 3.44
8 Laboratory and clinical evaluation of carbenicillin (carboxybenzyl penicillin). Antimicrob Agents Chemother (Bethesda) 1968 2.51
9 Spectinomycin and penicillin G in the treatment of gonorrhea. A comparative evaluation. JAMA 1972 2.30
10 Significance of bacterial variants in urine of patients with chronic bacteriuria. J Clin Invest 1965 2.18
11 Factors influencing in vitro susceptibility to the cephalosporins and clinical trial of an oral cephalosporin, cephaloglycin. Antimicrob Agents Chemother (Bethesda) 1966 1.99
12 In vitro evaluation of cefoxitin and cefamandole. Antimicrob Agents Chemother 1976 1.78
13 Treatment of the acute urethral syndrome. N Engl J Med 1981 1.71
14 Diphtheria among alcoholic urban adults. A decade of experience in Seattle. Ann Intern Med 1989 1.67
15 Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med 1980 1.61
16 Ampicillin in the treatment of enterococcal endocarditis. Ann Intern Med 1966 1.58
17 Evaluation of an indanyl ester of carbenicillin. Antimicrob Agents Chemother (Bethesda) 1970 1.58
18 Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986 1.57
19 Single-dose aqueous procaine penicillin G therapy for gonorrhea: use of probenecid and cause of treatment failure. J Infect Dis 1973 1.54
20 Evaluation of a new cephalosporin antibiotic, cephapirin. Antimicrob Agents Chemother 1972 1.50
21 Studies on the epidemiology of Escherichia coli infections. V. Factors influencing acquisition of specific serologic groups. J Clin Invest 1967 1.48
22 Relapse and reinfection in chronic bacteriuria. II. The correlation between site of infection and pattern of recurrence in chronic bacteriuria. N Engl J Med 1968 1.40
23 In vitro evaluation of a new quinolone antibacterial. Antimicrob Agents Chemother 1975 1.38
24 Nephrotoxicity due to cephaloridine: a light- and electron-microscopic study in rabbits. J Infect Dis 1970 1.35
25 Recovery of Neisseria gonorrhoeae from "Sterile" synovial fluid in gonococcal arthritis. N Engl J Med 1971 1.35
26 New cephalosporin antibiotic--cephaloridine. Clinical and laboratory evaluation. Arch Intern Med 1967 1.34
27 Treatment of cystitis in women with a single dose of trimethoprim-sulfamethoxazole. Rev Infect Dis 1982 1.33
28 Comparison of five aminocyclitol antibiotics in vitro against Enterobacteriaceae and Pseudomonas. Antimicrob Agents Chemother 1973 1.31
29 Antibacterial activity of a new parenteral cephalosporin--HR 756: comparison with cefamandole and ceforanide. Antimicrob Agents Chemother 1979 1.30
30 Comparative therapeutic and pharmacological evaluation of amoxicillin and ampicillin plus probenecid for the treatment of gonorrhea. Antimicrob Agents Chemother 1974 1.26
31 Gentamicin nephrotoxicity: failure of three cephalosporins to potentiate injury in rats. Antimicrob Agents Chemother 1975 1.24
32 Effect of bacteriuria on renal concentrating mechanisms. Ann Intern Med 1969 1.19
33 Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother 1977 1.19
34 In vitro activity of cinoxacin, an organic acid antibacterial. Antimicrob Agents Chemother 1975 1.18
35 Relapse and reinfection in chronic bacteriuria. N Engl J Med 1966 1.17
36 Emergence of resistant organisms as a function of dose in oxolinic acid therapy. Am J Med Sci 1971 1.15
37 Cefazolin in the treatment of bacterial pneumonia. J Infect Dis 1973 1.13
38 The role of carbenicillin in treatment of infections of the urinary tract. J Infect Dis 1970 1.11
39 Urinary-tract infection: localisation and virulence of Escherichia coli. Lancet 1975 1.11
40 Management of recurrent urinary tract infections with patient-administered single-dose therapy. Ann Intern Med 1985 1.10
41 The role of penicillin-induced bacterial variants in experimental pyelonephritis. J Exp Med 1967 1.10
42 Urinary-tract escherichia coli with cross-reactive antigens to encapsulated pyogenic bacteria. Lancet 1972 1.09
43 The problem of infections due to gram-negative organisms. Antimicrob Agents Chemother (Bethesda) 1966 1.06
44 Patterns of oropharyngeal and fecal flora in patients with acute leukemia. J Infect Dis 1981 1.05
45 Amoxicillin, a new penicillin antibiotic. Antimicrob Agents Chemother 1973 1.04
46 Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol 1966 1.03
47 Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics. Antimicrob Agents Chemother 1984 1.02
48 In vitro and in vivo evaluation of cephalexin. Antimicrob Agents Chemother (Bethesda) 1968 1.01
49 Nosocomial infection of the urinary tract. Am J Med 1981 1.00
50 In vitro evaluation of a new oral cephalosporin, cefatrizine (BL-s640). Antimicrob Agents Chemother 1975 0.99
51 Studies on the epidemiology of Escherichia coli, 1960-1968. J Infect Dis 1969 0.96
52 Nephrotoxicity of cephalosporin antibiotics in experimental animals. J Infect Dis 1973 0.95
53 Ampicillin. Med Clin North Am 1970 0.92
54 Activity of broad-spectrum antibiotics against enterococci and their efficacy in enterococcal endocarditis. Ann N Y Acad Sci 1967 0.91
55 Gonorrhea. Trimethoprim-sulfamethoxazole in the treatment of gonococcal urethritis: clinical and laboratory correlates. J Infect Dis 1973 0.91
56 Kanamycin in urinary tract infections. Ann N Y Acad Sci 1966 0.90
57 Laboratory and clinical evaluation of rifampicin. Am J Med Sci 1968 0.89
58 Disparity between inhibitory and killing effects of BL-P1654. Antimicrob Agents Chemother 1975 0.89
59 Susceptibility of Enterobacteriaceae to nitrofurantoin correlated with eradication of bacteriuria. Antimicrob Agents Chemother (Bethesda) 1966 0.88
60 Screening for cross-reacting capsular polysaccharide K antigens of Escherichia coli using antiserum agar. J Clin Microbiol 1977 0.87
61 Prospective pricing system and its effect on the principles and practice of infectious diseases. Am J Med 1985 0.86
62 Further evidence for epidemiological virulence of Escherichia coli. Antimicrob Agents Chemother (Bethesda) 1965 0.85
63 Amoxicillin in the treatment of urinary tract infections. J Infect Dis 1974 0.84
64 Galactose-deficient endotoxin from urinary Escherichia coli. Infect Immun 1973 0.82
65 Single-dose oral therapy for uncomplicated gonorrhea: comparison of amoxicillin and ampicillin given with and without probenecid. J Infect Dis 1974 0.81
66 Serum antibody response in renal versus bladder bacteriuria. J Infect Dis 1971 0.81
67 Gentamicin and tobramycin Kinetics. Clin Pharmacol Ther 1982 0.79
68 Urinary prophylaxis with trimethoprim and trimethoprim-sulfamethoxazole: efficacy, influence on the natural history of recurrent bacteriuria, and cost control. Rev Infect Dis 1982 0.79
69 Failure of urinary beta-glucuronidase activity to localize the site of urinary tract infection. Appl Microbiol 1971 0.79
70 Is antimicrobial prophylaxis of urinary tract infections cost effective? Ann Intern Med 1981 0.77
71 Alternative antibiotics for the penicillin-sensitive patient. Hosp Pract (Off Ed) 1981 0.77
72 The correlation between site on infection and maximal concentrating ability in bacteriuria. J Infect Dis 1969 0.77
73 Cefazolin in the treatment of gonorrhea. J Infect Dis 1973 0.76
74 The new penicillins and their proper use. Ann Intern Med 1966 0.75
75 Escherichia coli epidemiology, 1960-1968. Trans Am Clin Climatol Assoc 1969 0.75
76 In vitro comparison of dibekacin and gentamicin activities. Antimicrob Agents Chemother 1981 0.75
77 Sodium ampicillin given parenterally. Arch Intern Med 1966 0.75
78 Panel discussion of the treatment of serious Gram-negative infections. Postgrad Med J 1971 0.75
79 Staphylococcal endarteritis in a renal artery-inferior vena cava fistula. Arch Intern Med 1967 0.75
80 Some current concepts of urinary tract infections. Dis Mon 1970 0.75
81 Therapeutic principles in the treatment of urinary tract infections and pyelonephritis. Adv Intern Med 1972 0.75
82 Current therapy of bacterial pneumonias. Med Clin North Am 1967 0.75
83 Rash and hyperglycemia. That wasn't diabetic. Hosp Pract (Off Ed) 1985 0.75
84 Urinary tract infection. Adv Intern Med 1983 0.75
85 Cephalosporins and related antibiotics: an overview. Rev Infect Dis 1983 0.75
86 Localization of the site of recurrent urinary tract infection in women. Urol Clin North Am 1975 0.75
87 Muscle weakness in the middle of the night. Hosp Pract (Off Ed) 1984 0.75
88 In-vitro activity of Sch 29482--a new oral beta-lactam antibiotic. J Antimicrob Chemother 1982 0.75
89 A medical student who treated himself. Hosp Pract (Off Ed) 1985 0.75
90 New concepts in genitourinary tract infections. JAMA 1981 0.75
91 Susceptibility of gram-negative pathogens to the combination of dicloxacillin and hetacillin. Antimicrob Agents Chemother (Bethesda) 1967 0.75
92 A depressed nurse with hypoglycemia. Hosp Pract (Off Ed) 1985 0.75
93 The treatment of urinary-tract infections with an oral carbenicillin. J Infect Dis 1973 0.75
94 Optimal duration of treatment of chronic urinary tract infection. Ann Intern Med 1968 0.75
95 Comparison of oxafuradene and nitrofurantoin in vitro and clinical assessment of oxafuradene in bacteriuria. Antimicrob Agents Chemother (Bethesda) 1967 0.75
96 Foul breath and a productive cough. Hosp Pract (Off Ed) 1985 0.75
97 Round table: optimal duration of antibiotic therapy in severe bacterial infections. Antimicrob Agents Chemother (Bethesda) 1967 0.75
98 The correlation between site of infection and pattern of recurrence in chronic bacteriuria. Trans Assoc Am Physicians 1967 0.75
99 Recurrent hematemesis and diffuse 'gooseflesh'. Hosp Pract (Off Ed) 1984 0.75
100 Study of urinary infections by catheterization. N Engl J Med 1968 0.75
101 Urinary tract infections. Hosp Pract 1980 0.75
102 Bacteriuria in noninfectious renal disease. Am J Med Sci 1969 0.75
103 Treatment of opportunistic infections complicating antibiotic therapy. Mod Treat 1966 0.75
104 Complications of antimicrobial therapy. Del Med J 1971 0.75
105 Cefazolin and Staphylococcus aureus endocarditis. JAMA 1977 0.75
106 Therapeutic guidelines in the management of urinary tract infections and pyelonephritis. Urol Clin North Am 1975 0.75
107 Extended-spectrum cephalosporins and related beta-lactams. J Antimicrob Chemother 1982 0.75
108 Successful psoriasis treatment then sudden 'cytotoxicity'. Hosp Pract (Off Ed) 1984 0.75
109 An AIDS patient who died too soon. Hosp Pract (Off Ed) 1985 0.75
110 Antimicrobial therapy in patients sensitive to penicillin. J Chronic Dis 1967 0.75
111 Premature emphysema and a suspicious family history. Hosp Pract (Off Ed) 1984 0.75
112 Using tetracycline in the treatment of pustular acne. West J Med 1976 0.75
113 Differentiation of upper from lower urinary tract infections. Del Med J 1971 0.75
114 Emergence of resistance in Pseudomonas during carbenicillin therapy. Antimicrob Agents Chemother (Bethesda) 1969 0.75
115 Ceftizoxime treatment of pneumonia, cellulitis and other infections in 120 hospitalized patients. J Antimicrob Chemother 1982 0.75
116 Evaluation of phosphonomycin, a new cell wall-active antibiotic. Antimicrob Agents Chemother (Bethesda) 1969 0.75
117 An old woman with an intestinal obstruction. Hosp Pract (Off Ed) 1985 0.75